Skip to main content

Table 3 CRASH Scoring System

From: The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients

Item

Score

Diastolic Blood Pressure

0: ≤72 mmHg

1: > 72 mmHg

IADL

0 = 8

1: < 8

LDH

0: ≤ 0.74 x ULN

2: >  0.74 x ULN

ECOG PS

0: 0

1: 1–2

2: 3–4

MMS

0: 30;

2: < 30

MNA

0: 28–30

2: < 28

Chemotherapy risk (MAX2)

0: arm B (FU/LV + Pani)

1: arm A (FOLFOX+Pani)